The evidence on peptides — delivered weekly. Subscribe free →

Alamandine

low risk

Also: Ala1-Ang(1-7) · Alamandine heptapeptide

Preliminary Research Only

Alamandine is a recently discovered heptapeptide member of the renin-angiotensin system, related to Angiotensin (1-7) but acting on MrgD receptors instead of Mas receptors. Shows cardiovascular and anti-fibrotic effects in animal models. Human data is very limited.

Molecular Weight
899.1 Da
Formula
C34H49N9O9
Common Dosing
Not standardized for humans; IV and SC in animal studies
Category
research
Last Reviewed
2025-01-15

Reported Benefits

Cardiovascular/anti-fibrotic

Preliminary 12 studies

Animal models show cardiac fibrosis reduction and blood pressure lowering via MrgD activation.

Mechanism of Action

Activates MrgD (Mas-related G protein-coupled receptor D); counter-regulatory to Angiotensin II; vasodilatory and anti-fibrotic effects in cardiac and renal tissue.

Novel RAS Member

Alamandine was only characterized in 2013. It represents a new branch of the renin-angiotensin system with therapeutic potential distinct from both Angiotensin (1-7) and classical ACE inhibitors. Human research is in early stages.

✦ Sponsored

Stop Guessing About Your Health. Start Optimizing It.

Advanced diagnostics and licensed medical providers delivering personalized longevity care to uncover root causes, optimize health, and track progress virtually or in person.

Learn More →
Nava Health

Regulatory Status

Research Only

Safety Profile

Side Effects

  • •Hypotension (potential)

Contraindications

  • •Severe hypotension
  • •Pregnancy

Primary Uses

Cardiovascular protectionAnti-fibroticAnti-hypertension

Related Peptides

Angiotensin (1-7)BPC-157

Used For

›Cardiovascular Health

Planning a protocol?

Use the AI Stack Builder to generate a phased schedule, compatibility analysis, and monitoring checklist.

Stack Builder → Protocol Builder →

Weekly Briefing

Regulatory updates + new study breakdowns.

For Practitioners

Do you prescribe Alamandine?

Get in front of patients who've already researched this protocol and are ready to consult. Featured listings from $199/mo.

Get Listed →
Disclaimer: This information is for educational and research purposes only. Not medical advice. Consult a qualified healthcare provider before using any compound.